Repair of interstrand crosslinks (ICLs) requires the coordinated action of the intra-S-phase checkpoint and the Fanconi anaemia pathway, which promote ICL incision, translesion synthesis and homologous recombination (reviewed in refs 1, 2). Previous studies have implicated the 39-59 superfamily 2 helicase HELQ in ICL repair in Drosophila melanogaster (MUS301 (ref.
Repair of interstrand crosslinks (ICLs) requires the coordinated action of the intra-S-phase checkpoint and the Fanconi anaemia pathway, which promote ICL incision, translesion synthesis and homologous recombination (reviewed in refs 1, 2) . Previous studies have implicated the 39-59 superfamily 2 helicase HELQ in ICL repair in Drosophila melanogaster (MUS301 (ref. 3) ) and Caenorhabditis elegans (HELQ-1 (ref. 4) ). Although in vitro analysis suggests that HELQ preferentially unwinds synthetic replication fork substrates with 39 single-stranded DNA overhangs and also disrupts protein-DNA interactions while translocating along DNA 5, 6 , little is known regarding its functions in mammalian organisms. Here we report that HELQ helicase-deficient mice exhibit subfertility, germ cell attrition, ICL sensitivity and tumour predisposition, with Helq heterozygous mice exhibiting a similar, albeit less severe, phenotype than the null, indicative of haploinsufficiency. We establish that HELQ interacts directly with the RAD51 paralogue complex BCDX2 and functions in parallel to the Fanconi anaemia pathway to promote efficient homologous recombination at damaged replication forks. Thus, our results reveal a critical role for HELQ in replicationcoupled DNA repair, germ cell maintenance and tumour suppression in mammals.
To examine the effect of HELQ deficiency in vertebrates, we generated a Helq DC -deficient mouse strain that is truncated at the carboxy terminus of HELQ (Fig. 1a, b and Extended Data Fig. 1a , b) and results in loss of detectable HELQ protein ( Fig. 1d and Extended Data Fig. 1c ). Although Helq DC/DC mice are viable ( Fig. 1c ), are born in normal Mendelian ratios and lack growth or developmental abnormalities (Extended Data Fig. 1d, e ), breeding experiments with Helq DC/DC mutant pairs revealed a fertility defect. Eight heterozygous and 8 homozygous pairs were mated continuously for 5-6 months, resulting in 320 offspring in the case of heterozygotes (an average of 6.1 litters and 40 pups each) but only 38 pups in the case of homozygotes (1.4 litters and 4.7 pups per pair). Mating of mutants to control animals revealed that females contribute more to this phenotype than males (Fig. 1e ).
Consistent with a fertility defect, Helq DC/DC testes were smaller than those of wild-type males (0.58% of body weight for wild type versus 0.38% for mutants ( Fig. 1f) ). Histological analysis of testes revealed many normal tubules but also regions of atrophy in the mutants ( Fig. 1g and Extended Data Fig. 1g -l). Dysgenesis/atrophy was even more pronounced in Helq DC/DC ovaries ( Fig. 1g and Extended Data Fig. 1f ). A possible stem cell origin was investigated as no particular subset of spermatocytes appeared affected (Extended Data Fig. 1g-l) . Indeed, Helq DC/DC adults had significantly fewer c-KIT (also known as KIT) 1 spermatogonia than controls (Extended Data Fig. 2a, b ). As atrophy was not linked to ageing (Extended Data Fig. 2c ), a developmental origin was examined; tubules from 5-day-old wild-type mice contained sixfold more spermatogonia than mutants (Fig. 1h ), indicating that atrophic tubules in mutant adults may primarily arise from reduced spermatogonial stem cell pools during development.
The effect of HELQ deficiency during organismal ageing revealed that tumour-free survival was significantly reduced in Helq mutants ( Fig. 1i and Extended Data Fig. 2d ), with twice as many Helq DC/DC mice developing two or more primary tumours in comparison to controls ( Fig. 1j ). Ovarian tumours (resembling granulosa and other sex cord stromal tumours; Extended Data Fig. 3b -f) and pituitary adenomas (Extended Data Fig. 3g -j) were the most prominent tumour types in female mice, with incidences of 40% in the case of ovarian tumours and 30% in the case of pituitary tumours (Fig. 1k ). Unexpectedly, Helq 1/DC heterozygous females also presented with ovarian pathology similar to that of younger mutant females (Extended Data Fig. 2d ). Pathology included cystic (4 out of 7 mice) and dysgenic/atrophic (5 out of 7) ovaries with few or no maturing follicles (7 out of 7) and luteinized stroma (2 out of 7). Helq 1/DC heterozygous females also frequently displayed pituitary (5 out of 7 mice), Harderian gland (3 out of 7) and gastrointestinal (3 out of 7) adenomas, polyps and hyperplasias. Although these phenotypes are less severe than observed in the Helq DC/DC homozygous mice, the data reveal that loss of a single allele of Helq confers haploinsufficiency in mice.
The phenotype of Helq DC/DC mice is similar to that observed in mouse models of Fanconi anaemia 7 . Haematopoietic stem and progenitor cell (HSPC) defects and sensitivity to ICLs are also hallmarks of Fanconi anaemia and were therefore examined in Helq mutants. Although bone marrow HSPCs from Helq DC/DC mice exhibit hypersensitivity to the ICL agent mitomycin C (MMC; Extended Data Fig. 4a ), Helq DC/DC HSPCs were not compromised in numbers (Extended Data Fig. 4b , c), proliferative capacity (Extended Data Fig. 4d , e) or engraftment (Extended Data Fig. 4f -i). HELQ-deficient cells exhibited hypersensitivity to replication blocking agents such as MMC and camptothecin (CPT; Fig. 2a, b ), but not to ionizing radiation or ultraviolet radiation ( Fig. 2c, d ). Helq DC/DC cells also exhibited significantly more chromatid breaks and radial chromosomes than control cells upon treatment with mitomycin C (MMC; Fig. 2e , j). Silencing of HELQ by short interfering RNA (siRNA) in human cells resulted in similar phenotypes (Extended Data Fig. 4j ).
To examine the phenotypic relationship between HELQ and the Fanconi anaemia pathway we generated Helq DC/DC Fancd2 2/2 doublemutant mice (the Fancd2 strain is described in ref. 8) . Double mutants were born in Mendelian ratios (Extended Data Fig. 4k ) and growth and appearance were normal. Surprisingly, testes from double mutants were significantly smaller than single mutants and all tubules were atrophic, containing only Sertoli cells ( Fig. 2f, g) . Similarly, double-mutant cells exhibited greater sensitivity to MMC and CPT than either singlemutant ( Fig. 2h , i) and spontaneous and MMC-induced chromosomal aberrations were significantly increased over the Helq single mutant ( Fig. 2j ). These results suggest that HELQ and FANCD2 act in parallel ICL repair pathways.
To gain insight into the function of HELQ during DNA repair, we performed proteomic analysis of proteins co-precipitated with Flagtagged HELQ. Mass spectrometry revealed several checkpoint and DNA repair proteins, including the replication checkpoint kinase ATR, the single-stranded DNA binding protein RPA70 (also known as RPA1), the four components of the BCDX2 complex required for homologous recombination, and the FANCD2-FANCI heterodimer that functions in the Fanconi anaemia pathway (Fig. 3a, b and Extended Data Fig. 5a ). Interaction partners identified by mass spectrometry were confirmed via immunoprecipitation/western blot ( Fig. 3c ). Reciprocal immunoprecipitation of RAD51C confirmed its association with Flag-HELQ ( Fig. 3d ), and endogenous HELQ was detected in RAD51C immunoprecipitates from 293T cells and vice versa ( Fig. 3e ). Recombinant BCDX2 proteins purified from either insect cells or bacteria also bound to purified Flag-HELQ but not to ALC1-Flag or Flag controls ( Fig. 3f ). Intriguingly, XRCC3, a component of the RAD51C-XRCC3 (CX3) RAD51 paralogue complex, was not detected by either mass spectrometry or western blotting of Flag-HELQ immunoprecipitates (Fig. 3c ). Furthermore, HELQ was not found in reciprocal immunoprecipitates with endogenous XRCC3 (Extended Data Fig. 5c ). These data indicate that HELQ interacts directly with the BCDX2 complex but not with the CX3 complex.
As ATR, RPA70, the BCDX2 complex and FANCD2-FANCI all respond to stalled replication forks, we examined the localization of green fluorescent protein-tagged HELQ (HELQ-GFP) expressed in NIH 3T3 cells 9 . Subcellular fractionation revealed that HELQ-GFP is enriched on chromatin in response to replication fork stalling with either MMC or aphidicolin, and this is compromised by ATR inhibition ( Fig. 3g and Extended Data Fig. 5e-g) .
To determine the possible underlying cause of the defect in HELQdeficient cells we examined replication dynamics, indices of checkpoint activation, Fanconi anaemia pathway activation, double-stranded break (DSB) formation, and the integrity of homologous recombination. Replication fork extension rates in Helq DC/DC cells were significantly lower than in wild-type cells (Extended Data Fig. 6d , e) and this was exacerbated by treatment with CPT (Extended Data Fig. 6d ). Replication UV (J m -2 ) 
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fork tract asymmetry was also evident in mutants relative to controls indicative of increased fork stalling/collapse (Extended Data Fig. 6f , g).
Checkpoint activation as measured by phosphorylation of ATM, CHK1 and CHK2 (also known as CHEK1 and CHEK2, respectively) and cH2AX in response to DNA damage was unaffected by loss of HELQ in either mouse or human cells (Extended Data Fig. 7a-d ). Furthermore, HELQ-deficient cells exhibited constitutive FANCD2 monoubiquitination, indicating that HELQ is dispensable for this modification (Fig. 4a ). Assessment of RAD51 recruitment to damaged replication forks revealed that RAD51 is enriched on chromatin in response to MMC treatment in HELQ-deficient mouse and human cells ( Fig. 4b and Extended Data Fig. 7e , 8a) and RAD51, RPA (also known as RPA1) and cH2AX accumulate in repair foci ( Fig. 4c and Extended Data Fig. 7e -g). However, RAD51 and cH2AX persisted on chromatin and remained present in repair foci at later time points in HELQ-deficient mouse and human cells (Fig. 4b, c and Extended Data Fig. 7e , f), suggesting that the defect in the absence of HELQ occurs at a step downstream of RAD51 recruitment to damaged replication forks. Pulsed field gel electrophoresis revealed that DSBs form in Helq and Fancd2 single and double mutant cells after MMC treatment, but that these lesions persist at later time points, indicating that DSBs induced at ICLs are not efficiently repaired ( Fig. 4d ). siRNA-induced depletion of HELQ resulted in a two-to threefold decrease in homologous recombination efficiency, implicating HELQ in promoting homologous recombination ( Fig. 4e and Extended Data Fig. 8b ). Furthermore, clonogenic survival of HELQdeficient mouse and human cells were significantly compromised in response to poly-ADP ribose polymerase (PARP) inhibition, which is a hallmark of homologous recombination-deficient cells 10 ( Fig. 4f and Extended Data Fig. 8c ). It is notable that the HELQ interacting protein and BCDX2 complex factor, RAD51D, is also required for PARP inhibitor resistance 11 .
In summary, our results uncover a critical role for HELQ in germ cell maintenance and tumour suppression in mammals, which we attribute to a role in replication-coupled DNA repair. The interaction between HELQ and the RAD51 paralogue BCDX2 complex may provide molecular insight into the HELQ phenotype and its role in tumorigenesis, as the BCDX2 complex functions to promote replicationcoupled homologous recombination, RAD51C has been implicated in a Fanconi anaemia-like disorder 12 , and mutations in RAD51B and RAD51D are associated with hereditary ovarian cancer in humans 11, [13] [14] [15] [16] [17] [18] . These findings suggest HELQ as a strong candidate for screening in human cancers and also explain why mutations in D. melanogaster homologues of HELQ, RAD51, and the two RAD51 paralogues (MUS301 (also known as SPN-C), SPN-A, SPN-B and SPN-D, respectively) confer a very similar phenotype 19 . Finally, our findings help to explain the prevalence of non-synonymous variants in HELQ, which are significantly associated with upper aerodigestive tract cancers, particularly amongst smokers 20 ; and variants in HELQ associated with early menopause 21 , which may reflect the germ cell defects and ovarian dysgenesis observed in HELQ-deficient mice. Helq C/ Figure 4 | HELQ influences DNA repair and homologous recombination efficiency. a, Lysates from immortalized mouse cells, grown under physiological O 2 and treated with or without 3 mM aphidicolin (APH) for 6 h, were probed for FANCD2. Wild-type (WT), HELQ-deficient (HQ), unmodified (S) and ubiquitinated (L) forms of FANCD2 were used. b, Chromatin fractions from immortalized mouse cells, probed for RAD51, histone H3 and a-tubulin at the indicated time points (hours) following treatment with or without 100 ng ml 21 MMC. c, Left, representative images of RAD51 focus formation in immortalized mouse cells at the indicated time points (hours) following treatment with 1 mM MMC. Right, quantification of RAD51 foci at the indicated time points. d, Pulsed field gel electrophoresis of genomic DNA from immortalized cells treated with or without 1 mM MMC for 1 h and recovered for the indicated number of hours. un, undamaged. Wells, intact DNA; arrow, band containing large chromosomal fragments (10-0.45 megabases); below the arrow, smaller fragments resolved by size. e, Homologous recombination frequencies in direct repeat (DR)-GFP reporter cells treated with the indicated siRNAs. LUC, luciferase. *P,0.05; **P,0.001. f, Clonogenic survival assays of immortalized mouse cells exposed to PARP inhibitor (PARPi). Error bars represent s.e.m.
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METHODS SUMMARY
HELQ-deficient mice were generated from a commercially available embryonic stem cell clone (clone ID: RRF112, Bay Genomics, University of California, Davis). All strains were maintained on a mixed B6/129 background. Testes for histology were fixed in Bouin's solution and periodic acid-Schiff/haematoxylin stained; all other tissues were fixed in neutral buffered formalin and stained with haematoxylin and eosin. Bone marrow cells were collected and analysed by FACS, colony formation and transplantation as described previously 8, 22, 23 . HELQ-Flag, Flag, and ALC1-Flag cell lines were generated using the HEK293 Flp-In system according to the manufacturer's protocol (Invitrogen). HELQ-GFP-expressing NIH3T3 cells were generated according to the bacterial artificial chromosome recombineering method described previously 9 . Pulse field gel electrophoresis was carried out similar to the method described in ref. 24 . Isolation of HELQ-Flag immunocomplexes entailed lysis of cells in the presence of benzonase to prevent non-specific DNAbridging of proteins. Flag immunoprecipitates for mass spectrometry analysis were eluted by boiling in SDS-PAGE sample buffer and processed using standard methods. The Biological General Repository for Interaction Data sets (BioGRID, http://thebiogrid.org/), the Molecular INTeraction database (MINT, http://mint. bio.uniroma2.it/mint) and Search Tool for the Retrieval of Interacting Genes/ Proteins database (STRING, http://string-db.org/) were used to compile the interaction network. For assays of in vitro binding to purified His-tagged BCDX2, Flagtagged proteins were purified by washing immune-complexed beads four times with buffer containing 1 M NaCl. Purified Flag proteins were then incubated with recombinant BCDX2 complex, washed and eluted for analysis. Chromatin fractionation was carried out using modified versions of previously established methods 25, 26 . For siRNA transfections of U2OS cells, cells were subjected to two rounds of reverse transfections using siGENOME siRNA and Dharmafect1 (Thermofisher) according to the manufacturer's protocol. Histology/immunohistochemistry, primary cell line derivation and immortalization, immunofluorescence, assays for clonogenic survival, metaphase aberrations, micronuclei and DNA combing were carried out using standard procedures.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Mouse strains, maintenance, localization of genetrap, genotyping. All mice were housed and maintained according to the Home Office guidance outlined in the Animals Scientific Procedures Act. All strains were maintained on a mixed B6/ 129 background.
A commercially available embryonic stem cell clone (clone ID: RRF112, Bay Genomics, University of California, Davis) harbouring the trapped allele of Helq was obtained. The position of the b-geo gene trap cassette from the pGT0LxF vector was determined via splinkerette PCR 27 using a modified version of the method described in ref. 28 . In brief, 3 mg genomic DNA from Helq gene-trapped embryonic stem cells was digested overnight at 37 uC with BfaI. Splinkerette primers were annealed in SuRE Buffer M (Roche) by heating to 95 uC, followed by cooling by 1 uC increments for 15 s each. A total of 40 pmol of the annealed splinkerette adaptor was ligated to 600 ng of BfaI-digested genomic DNA, followed by passage over a PCR purification column (Qiagen). The splinkerette-adapted genomic DNA was re-digested with BfaI for 1 h (eliminating potential background due to splinkerette ligation to partially digested genomic DNA fragments) and re-purified. Primary and nested PCRs were performed using genetrap-and splinkerette-specific primers, with 0.4% of the primary PCR used in the nested round. Nested PCR products were gel purified and sequenced using standard methods.
The Helq DC mouse strain was generated using standard transgenic technology. For more background and discussion pertaining to this and other aspects of the manuscript, see elsewhere in the Methods and Extended Data. FANCD2-deficient mice were described previously 8 . Mice were identified using standard ear snip methods, and snips were used for genomic DNA preparation using the HotSHOT method 29 for use in genotype PCR. Helq wild-type, heterozygous and mutant mice were genotyped in a single reaction using the following primers: pGT0LxF_F2-CA GGGTTTTCCCAGTCACGAC (genetrap-specific primer), mHELQint11_F8-GT CCTTGTGCCCAAAGTACAG (wild-type-specific primer), mHELQint11_R5-CC TAGTGTGGCTTATCTCCTTCTTC (common primer). Fancd2 mice were genotyped according to the previously described method 8 .
Breedings to establish Mendelian ratios and fertility consisted of continuously mated, individually housed pairs. The Helq Fancd2 double-mutant strain was established from mating of double heterozygous Helq 1/DC Fancd2 1/2 mice. Weights of Helq mice were measured weekly starting at 10 days post-partum. The tumour watch cohort was established using littermate controls wherever possible and mice were regularly monitored for signs of deterioration using a scoring system that will be described in a separate publication. Mice were euthanized before terminal end points were reached. Statistics. For survival study, sample size was estimated using standard power calculation methods in order to measure a difference of 3-4 months in survival between mutant and control groups. For Helq and Helq Fancd2 matings, deviations from expected Mendelian ratios were tested by Chi-squared analysis (P . 0.25 for both strains). For fertility analysis, the number of litters and pups were tested using Kruskal-Wallace analysis of variance. The Gaussian approximation of P values indicated that medians varied significantly between the groups (P 5 0.0019 for litters, P 5 0.0014 for pups). Dunn's multiple comparison posttest was used to compare specific sample pairs. Results of P value calculations for both litters and pups were the same, and are the values indicated on the graph (P , 0.001 for control versus mutant pairs, P 5 not significant for control versus male or female mutant pairs). For wild-type versus Helq mutant testes weights, the Mann-Whitney test was used to analyse whether the weights differed between the two groups. Gaussian approximation was used for calculation of the indicated P value (P , 0.0001). For wild-type and Helq mutant testes weights versus age, linear regression was used to generate slopes of best-fit lines which were tested for deviation of slope from zero. R 2 and P values indicated on the graph demonstrate that although there is a correlation between reduced testes weight and age in wildtype mice (P 5 0.0091), there is no correlation between testes weight and age for Helq mutants (P 5 0.78). For spermatogonia numbers in wild-type versus Helq mutant neonatal testes, the Mann-Whitney test was used to analyse whether spermatogonia differed between the two groups. Gaussian approximation was used for calculation of the indicated P value (P , 0.0001). For MMC-induced metaphase aberrations in wild-type versus Helq mutant cell lines, the Mann-Whitney test was used to analyse whether radial chromosomes per metaphase differed between the two groups (P , 0.0001). For wild-type versus Helq and Fancd2 single-and double-mutant testes weights, the Kruskal-Wallace analysis of variance test was used. Gaussian approximation of the P value indicated that medians varied significantly between the groups (P , 0.0001). Dunn's multiple comparison post-test was used to compare specific sample pairs. Results of P value calculations are indicated on the graph (P , 0.001 for both wild-type versus Fancd2 single mutant and wild type versus Helq Fancd2 double mutant). For MMCinduced metaphase aberrations in wild-type versus Helq and Fancd2 single mutants and Helq Fancd2 double mutants, the Kruskal-Wallace analysis of variance test was used. Gaussian approximation of the P value indicated medians varied significantly between the groups (P , 0.0001). Dunn's multiple comparison post-test was used to compare specific sample pairs. Results of P value calculations for MMCdamaged samples are indicated on the graph (P , 0.001 for wild-type versus single and double mutants, P , 0.01 for Helq mutants versus double mutants, and P 5 not significant for Helq versus Fancd2 single mutants and for Fancd2 mutants versus double mutants). For HELQ-GFP chromatin recruitment upon ATR inhibitor treatment, Student's t-test was performed to determine whether the observed differences were statistically significant. For DNA combing of replication tracts from wild-type versus Helq mutant cells at atmospheric O 2 , and tracts from wildtype, Helq and Fancd2 single, and Helq Fancd2 double mutants at physiological O 2 , the Kruskal-Wallace analysis of variance test was used. Gaussian approximation of the P values indicated that medians varied significantly between the groups (P , 0.0001 for both experiments). Dunn's multiple comparison post-test was used to compare specific sample pairs. Results of P value calculations are indicated on the graphs (P , 0.01 for wild type versus Helq mutants and for undamaged versus CPT damaged Helq mutant cells; P , 0.001 for wild type versus single and double mutants). For wild type versus Helq mutant tumour watch, the Kaplan-Meier epithelial and stromal tumour-free survival curve was analysed with Mantel-Cox log-rank test for P value calculation (P 5 0.009). Histology, immunohistochemistry sample preparation and reagents. For all histology, samples were paraffin embedded and sectioned at 4 mm. Testes for histology were fixed in Bouin's solution, Periodic acid-Schiff stained and haematoxylin counter-stained; all other tissues, including post-mortem tissues for analysis of tumour watch cohort, were fixed in 10% neutral buffered formalin (NBF) and stained with haematoxylin and eosin.
Immunohistochemistry was carried out using standard methods. In brief, testes for immunohistochemistry were NBF fixed and sections from adult mice were processed for c-KIT staining by microwaving in 0.01 M citrate buffer, pH 6, to unmask antigens. After incubation with c-KIT primary antibodies (Dako A4502, 1:600), samples were incubated with biotinylated secondary antibody (Vector) followed by incubation with Avidin Biotin Complex (Vector); slides were developed in 3, 39-diaminobenzidine (DAB) substrate (Vector) and counterstained in haematoxylin. Neonatal testis sections were similarly processed and labelled with antibodies against WT1 (Santa Cruz sc-192, 1:450). Cell line derivation. Ear fibroblasts for primary and SV40 immortalized cultures were generated as follows: mice were euthanized and ear tissue was collected using sterile scissors, ear fragments were rinsed twice in 70% ethanol followed by two rinses in PBS supplemented with 100 mg ml 21 kanamycin. Tissue was transferred into 0.3 ml of protease solution (4 mg ml 21 each of collagenase D and dispase in DMEM; filter sterilized), and incubated at 37 uC for 45 min. In total, 1.5 ml DMEM containing 10% FBS, 13 glutamine and 53 antibiotic-antimycotic solution were added to protease solution containing ear fragments, and samples were incubated at 37 uC overnight. Cells were dissociated by pipetting, passed through a 40-mm mesh cell strainer, and plated in DMEM as above except using 13 antibioticantimycotic solution. Cells were passaged upon reaching confluence to five dishes, and upon reaching confluence, cells were frozen at passage 1 or used immediately for immortalization or experiments.
Fibroblasts were immortalized via transfection with a vector expressing SV40 large T antigen. Constitutively expressed HELQ-Flag, Flag, and ALC1-Flag cell lines were generated using the 293 Flp-In system according to the manufacturer's protocol (Invitrogen). NIH3T3 cells stably expressing GFP-tagged mouse HELQ (consisting of a bacterial artificial chromosome (BAC) containing the entire Helq promoter and genomic locus) were generated according to the BAC recombineering method described previously 9 . These and all other cell lines used in this study (293T, HeLa, NIH3T3 and U2OS) were grown in DMEM supplemented with 10% FBS and L-glutamine. Cells were grown in 5% CO 2 incubators at atmospheric O 2 concentrations (,21%) with noted exceptions where samples were cultured at physiological O 2 concentrations (,5%).
For HELQ-GFP transient transfections in HeLa cells (Extended Data Fig. 3d ), human HELQ was cloned into the pcDNA6.2/C-EmGFP-DEST vector using Gateway technology (Invitrogen). The vector was transfected into HeLa cells with Lipofectamine 2000 using the manufacturer's protocol (Invitrogen). Live or paraformaldehyde (PFA)-fixed cells (fixed cells were counterstained with DAPI (49,6diamidino-2-phenylindole)) were visualized 48-96 h after transfection under epifluorescence using a Zeiss Axio Imager M1 microscope with an ORCA-ER camera (Hamamatsu), and images were acquired using the Volocity software (Improvision, Perkin Elmer). Clonogenic survival, metaphase spreads, growth and micronuclei analyses. For all experiments, fibroblast lines established from littermates or siblings were used wherever possible. Experiments involving primary cells were conducted in physiological O 2 using cell lines of similar passage number.
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For clonogenic survival assays, SV40 immortalized mouse ear fibroblasts and siRNA-treated U2OS cells were plated in triplicate on 10-cm dishes at clonal density, allowed to adhere for 8-16 h, and damage treatments administered (CPT medium was changed after 24 h). After 8-10 days of growth, plates were rinsed, fixed/stained in 20% ethanol/4% crystal violet (w/v), rinsed in distilled water and colonies tabulated. All results were normalized to untreated to adjust for plating efficiency and determine percentage survival. Survival experiments were carried out on at least two independent sets of mutant and control mouse cell lines, and in most cases cell lines were tested in at least two independent experiments. Similar results were obtained across all experiments and sets of cell lines.
For analysis of metaphase aberrations, SV40 immortalized cells were damaged as indicated and treated with colcemid (2 3 10 27 M) for 30 min, collected, swelled in hypotonic solution (0.075 M KCl) for 7 min at 37 uC, fixed and washed in icecold methanol-acetic acid (3:1), dropped on humid slides and briefly steamed over a 65 uC bath. Slides were dried, stained with Giemsa (Sigma) for 10 min, rinsed with distilled water, and coverslips were mounted (Permount, Fisher). For each sample $40 spreads were scored.
Growth kinetics of primary cells were determined using a modified 3T3 protocol to calculate cumulative population doublings. In brief, primary cells were collected, counted and 150,000 cells reseeded in triplicate 10-cm dishes every third day. Cumulative population doublings were calculated using the formula: log 10 (n/n 0 ) 3 3.32, in which n 5 number of cells collected after growth and n 0 5 number of cells seeded. Similar growth kinetics were obtained for three different mutant and control mouse embryonic fibroblasts and embryonic fibroblast cell line pairs.
Micronuclei were examined by seeding SV40 immortalized embryonic fibroblasts in 6-well dishes containing glass coverslips. The following day, cells were fixed in 4% PFA and stained with DAPI. For each sample $100 cells were scored. Bone marrow protocols, antibodies/reagents, analysis. Bone marrow cells were collected from 3-4-month-old control and Helq DC/DC mice and analysed for haematopoietic stem and progenitor cells (HSPCs) as described previously 8, 22 . For LSK (lineage 2 Sca-1 1 c-Kit 1 ) staining, cells were stained in Hank's balanced salt solution containing 2% FBS and 10 mM HEPES buffer (Gibco) using biotinylatedanti-lineage antibody cocktail (anti-Mac1a, Gr-1, Ter119, CD3e, CD4 and CD8a), phycoerythrin (PE)-Cy-7-anti-Sca-1 antibody (clone E13-161.7), and APC-antic-Kit antibody (clone 2B8), followed by staining with PE-streptavidin secondary antibody (all primary and secondary antibodies from BD Biosciences). The samples were acquired using a BD FACSAria high-speed sorter.
For c.f.u.-c assays, bone marrow cells were seeded in 12-well plates at a density of 7 3 10 4 cells per well in mouse MethoCult medium M3434 (StemCell Technologies) and haematopoietic colonies (c.f.u.-c) were counted at 7-10 days after culture. c.f.u.-c assays were used to determine the survival of bone marrow in presence of MMC. To determine the ex vivo clonal growth of murine HSPCs, a cobblestone area-forming cell (CAFC) assay was performed by a limiting dilution analysis of bone marrow in micro-cultures using the bone marrow stromal cell line FBMD-1 (refs 8, 23) . This assay quantifies a spectrum of haematopoietic cells that is wellvalidated to compare with other functional assays. Specifically, day-7 and day-14 CAFC correspond to early progenitor cells and to c.f.u.-spleen-day-12 cells, whereas the more primitive haematopoietic stem cells with long-term repopulating ability correspond to day-28 CAFC 23 .
Bone marrow transplantation was performed as described previously 8 . In brief, bone marrow cells (5 3 10 5 ) from control or Helq DC/DC mice (CD45.2 1 ) were mixed with 2.5 3 10 5 bone marrow supporting cells from CD45.1 1 congenic mice and transplanted into lethally irradiated CD45.1 1 congenic recipient mice. The donor cell engraftment efficiency in the recipient mice, after 17 weeks post-transplant, was determined by staining peripheral blood leukocytes with FITC-labelled anti-CD45.2 (clone 104) antibody. The percentage of donor-derived T cells, B cells and myeloid cells was determined by co-staining with PE-labelled anti-CD3e (clone 145-2C11), anti-B220 (clone RA3-6B2) and anti-Mac-1/Gr-1 antibodies (clones M1/70 and RB6-8C5), respectively, and analysed on a FACScan instrument (Becton Dickinson). All antibodies were from BD Biosciences. Mass spectrometry and proteomics. HELQ-Flag and Flag control cells were collected and lysed in benzonase lysis buffer (20 mM Tris-Cl, pH 7.5, 75 mM NaCl, 10% glycerol, 2 mM MgCl 2 , 0.5% NP40, 30 U ml 21 benzonase, protease inhibitors). NaCl concentration was adjusted to 150 mM, EDTA to 3 mM and lysates were cleared by centrifugation. Supernatants were pre-cleared with Protein G agarose beads for 30 min at 4 uC. Pre-cleared lysates were incubated with anti-Flag affinity agarose resin (Sigma) for 4 h at 4 uC. Beads were washed five times with wash buffer (20 mM Tris-Cl, pH 7.5, 150 mM NaCl, 3 mM EDTA, 0.5% NP40) and once with PBS. Bound proteins were eluted by boiling in SDS-PAGE sample buffer and eluates were resolved on NuPAGE Bis-Tris gels (Invitrogen) and stained with Sypro Ruby (Invitrogen). Gel slices were excised and processed for mass spectrometry using the Janus automated liquid handling system (PerkinElmer). Peptides were analysed by nanoscale capillary liquid chromatography-electrospray ionization/multi-stage mass spectrometry (LC-ESI MS/MS), data were processed using Mascot Distiller (Matrix Science) and exported to Scaffold for viewing (Proteome Software).
The Biological General Repository for Interaction Data sets (BioGRID, http:// thebiogrid.org/), the Molecular INTeraction database (MINT, http://mint.bio. uniroma2.it/mint), and Search Tool for the Retrieval of Interacting Genes/Proteins database (STRING, http://string-db.org/) were used to compile the protein interaction network. Cell lysates, in vitro binding assay and fractionation for western blot analyses. All cell lines used in this study were short tandem repeat-profiled and tested for mycoplasma infection before use. All lysis buffers were supplemented with protease inhibitor cocktail (Roche) and phosphatase inhibitors (Sigma).
For validation of mass spectrometry data, HELQ-Flag-and Flag-expressing cells were used. (This was due to our inability to validate these interactions using endogenous HELQ, stemming from the fact that it is expressed at very low levels in most human cell lines, and no antibodies were found to reliably immunoprecipitate the human version. Validation using endogenous mouse HELQ was similarly hindered by a lack of reagents available for detection of the mouse RAD51 paralogues.) Cells were lysed in the presence of benzonase and 2 mg of total protein were immunoprecipitated with anti-Flag affinity resin as above. Beads were washed, bound proteins eluted with 1 3 NuPAGE LDS sample buffer and analysed by western blot. Similar methods were employed using lysates prepared from 293T cells to examine endogenous HELQ or RAD51C coimmunoprecipitates.
For in vitro binding assays, HELQ-Flag, ALC1-Flag and Flag cells were lysed in the presence of benzonase and pre-cleared lysate was used for Flag immunoprecipitate as described above. Flag-immunocomplexed beads were then washed four times with a modified wash buffer containing 1 M NaCl to remove bound coprecipitates, and once with in vitro binding buffer (20 mM Tris-Cl, pH 7.5, 280 mM NaCl, 3 mM EDTA, 0.5% NP40). Washed beads were incubated with recombinant RAD51 paralogue BCDX2 complex (gift of S. West's laboratory) in binding buffer for 4 h at 4 uC and washed four times with the same buffer. Eluates were analysed by western blot.
GFP-tagged HELQ was stably expressed in NIH3T3 cells using a BAC recombineering method to C-terminally Flag/GFP-tag the BAC-containing full-length genomic Helq, which included the endogenous promoter. This allowed HELQ-GFP to be expressed at physiological levels.
For chromatin fractionation of embryonic fibroblasts and siRNA-treated U2OS cells, cells were treated with or without 3 mM aphidicolin for 6 h or with or without 1 mM MMC for 24 h, collected and fractionated using a modified version of the method described in ref. 26 : pellets were re-suspended in CSK buffer (10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA, pH 7, 0.5% Triton X-100), incubated for 10 min on ice (a small fraction of this was removed and SDS-PAGE sample buffer was added to obtain WCEs), pelleted at low speed and supernatants reserved as soluble fraction. Pellets were washed in CSK buffer, and re-pelleted. Pellets were re-suspended in benzonase CSK buffer (10 mM PIPES, pH 7.5, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 0.5% Triton X-100, 0.1 U ml 21 benzonase), lysates were incubated for 30 min at 37 uC, pelleted and supernatants reserved for chromatin fraction. Pellets were re-suspended in high-salt CSK (recipe as above except NaCl was added to 500 mM), lysates were incubated for 10 min on ice, cleared at high speed and supernatants pooled with benzonase CSK lysates to yield chromatin extracts 25 . In total, 25 mg of soluble and 10 mg of chromatin proteins were analysed by western blotting. Western blot, immunoprecipitated antibodies/reagents and siRNA oligonucleotides. Precast NuPAGE Bis-Tris or Tris-acetate gels and electrophoresis system were by Invitrogen. Western blotting transfers were carried out in BioRad transblot chambers and all blots were blocked and probed in 5% milk-phosphate buffer saline triton X100 (PBST) with the exception of p-CHK1 blots, which were processed in 3% BSA-Tris buffered saline triton X100 (TBST). Mouse and rabbit horseradish peroxidase-conjugated secondary antibodies were from ThermoFisher, and signals were visualized with ECL western blotting detection reagent (Amersham) or SuperSignal West Femto reagent (Thermoscientific).
Antibodies used for western blot analysis: Flag (Sigma F1804, 1:2,000), HELQ (Santa Cruz 81095, 1:200), His (Clontech 631212, 1:2,000), PARP1 (Trevigen 4338-ML-50, 1:1,000), CHK1 (Sigma C9358, 1:500), S345-P-CHK1 (Cell Signalling 2348, 1:500), CHK2/p-CHK2 (Upstate 05-649, 1:400), ATM (Sigma A1106, 1:2,000), S1981-p-ATM (Cell signalling 4526, 1:1,000), histone H3 (Abcam 10799, 1:2,000), a-tubulin (Sigma T6199, 1:2,000), RAD51 (Santa Cruz 8349, 1:200), FANCD2 (Epitomics 2986-1, 1:1,000), cH2AX (Cell Signalling 2577, 1:1,000), RPA32 (Abcam 12F3.3, 1:1,000), BRCA2 (Santa Cruz 8326, 1:200), TFIIH p89 (Santa Cruz 293, 1:200). All RAD51 paralogue antibodies were a kind gift from S. West's laboratory, as described in ref. 30 : RAD51B (IH3 mouse monoclonal antibody, 1:500), RAD51C (2H11 mouse monoclonal antibody, 1:500), RAD51D (5B3 mouse monoclonal antibody, 1:400), XRCC2 (7B7 mouse monoclonal antibody, 1:400), XRCC3 (10F1 mouse monoclonal antibody, 1:400).
Antibodies used for immunoprecipitation: RAD51C (R68 rabbit antibody), XRCC3 (10F1 mouse monoclonal antibody), mouse IgG (Abcam 18413) siRNA transfection and ATR inhibition. U2OS cells were subjected to two rounds of reverse transfections using siGENOME siRNA and Dharmafect1 (Thermofisher) according to the manufacturer's protocol. Thirty-six hours after the second transfection, cells were treated for 14 h with 3 mM aphidicolin. For ATR inhibition, 3 mM ATR inhibitor was added to cultures 30 min before aphidicolin treatment. Immunofluorescence. Cells were first washed in PBS and then fixed with 2% PFA at room temperature (18 uC) for 15 min, and then washed three times in PBS. The fixed cells were further permeabilized with 3% BSA in PBS plus 0.1% Triton X-100 for 30 min at room temperature. Primary antibodies (RAD51; 1:500, RPA; 1:1,000, cH2AX) were added and incubated at 37 uC for 1 h. After washing with PBS plus 0.1% Triton X-100, secondary antibodies (provided by Jackson ImmunoResearch) were applied and incubated for 1 h in the dark. The stained coverslips were mounted with prolong Gold Antifade reagent (Invitrogen). Imaging was carried out using Axio Imager (Zeiss) or Axioplan 2 Imaging (Zeiss) microscope and analysed by Axiovision software (Zeiss). Homologous recombination reporter assays. DSB repair efficiency by homologous recombination was measured in DR-GFP U2OS cells as described previously 34 . In brief, 48 h after the first round of siRNA transfection (40 nM) using Lipofectamine RNAiMAX (Invitrogen), cells were either mock-transfected (pcDNA3.1) or transfected with 0.6 mg of an I-SceI expression plasmid (pCBASce) together with siRNA (20 nM) using 3.6 ml of Lipofectamine 2000 (Invitrogen). The media was replaced 3 h after I-SceI transfection and cells were analysed for GFP expression by flow cytometry on a Cyan ADP (Dako) 72 h after I-SceI transfection. To confirm siRNA efficiency, western blotting was carried out on 50 mg of NP-40 lysates plus sonication run on 4-15% Precast SDS-PAGE gels (Bio-Rad). DNA combing. Replication tracts were labelled for 20 min with 20 mM iododeoxyuridine (IdU) (in atmospheric O 2 experiments, cells were treated with or without 2.5 mM CPT for the final 15 min of IdU labelling to test replication fork stalling/ restart), washed three times with PBS and labelled for 20 min with 200 mM chlorodeoxyuridine (CldU). Cells were washed, collected on ice, counted and embedded in agarose. Cells were digested in 2-3 changes of proteinase K buffer for 24 h at 50 uC. Plugs were washed for 5 3 10 min in Tris-EDTA followed by b-agarase digestion overnight at 42 uC. Genomic DNA was combed onto silanized coverslips (Genomic Vision) using a Molecular Combing System instrument (Genomic Vision), dried and stained using previously described methods 35 . Experiments were conducted on two separate sets of mutant and control cell lines with similar results obtained for both experiments. Pulsed field gel electrophoresis analysis. Immortalized embryonic fibroblasts were treated with or without MMC for 1 h and then allowed to recover for 16-48 h. Cells were collected and processed for pulsed field gel electrophoresis (PFGE) analysis similar to previously described methods 24 . In brief, cell suspensions were placed on ice, cell numbers counted and equivalent cell numbers or each genotype were embedded in agarose plugs in duplicate. Cells were digested by incubating plugs in proteinase K overnight at 50 uC, plugs were washed 4 3 1 h, sealed with low-melting-point agarose into the well of a 1% agarose/0.53 Tris/borate/EDTA (TBE) pulsed field gel, and run for 24 h on a Gene Navigator PFGE apparatus (Amersham) using the following conditions: running temperature: 13 uC; normalized to the number of Sertoli cells. c, Testis weights plotted by mouse age in days. Linear regression used to generate slope of best-fit line; tested best-fit line for deviation of slope from 0: R 2 and P values are indicated, revealing no correlation between age and testes weight for Helq mutants. d, Table of tumour frequency and tumour spectrum of Helq mutant and control mice showing data for all mice, females, and males in the tumour watch cohort. 129/B6 background phenomena are coloured in grey text, Helq mutant-specific effects are in black, and female-specific pathology is highlighted in pink.
